The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
A genetic mouse model for metastatic lung cancer with gender differences in survival
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lung adenocarcinoma mice carrying TP53 and KRAS mutations are highly aggressive and metastasize to multiple sites of intrathoracic and extrathoracic in a pattern similar to that of human lung cancer.253”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [253]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
Lang, G. A., Iwakuma, T., Suh, Y.-A., Liu, G., Rao, V. A., Parant, J. M., Valentin-Vega, Y. A., Terzian, T., Caldwell, L. C., Strong, L. C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.006 · Cited by 1,069
Self-citationClassification of Proliferative Pulmonary Lesions of the Mouse
Nikitin, A. Y., Alcaraz, A., Anver, M. R., Bronson, R. T., Cardiff, R. D., Dixon, D., Fraire, A. E., Gabrielson, E. W., Gunning, W. T., Haines, D. C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3376 · Cited by 334
Selective Evolution of Stromal Mesenchyme with p53 Loss in Response to Epithelial Tumorigenesis
Hill, R., Song, Y., Cardiff, R. D., & Van Dyke, T. (2005) · Cell · doi:10.1016/j.cell.2005.09.030 · Cited by 324
Research works printed but not linked: 36
- Abutaily AS, Addis BJ, Roche WR . (2002). Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies. J Clin Pathol 55: 662–668. · doi:10.1136/jcp.55.9.662
- Bach PB, Kattan MW, Thornquist MD, Kris MG, Tate RC, Barnett MJ et al. (2003). Variations in lung cancer risk among smokers. J Natl Cancer Inst 95: 470–478. · DOI · Paper page
- Bain C, Feskanich D, Speizer FE, Thun M, Hertzmark E, Rosner BA et al. (2004). Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst 96: 826–834. · DOI · Paper page
- Becher OJ, Holland EC . (2006). Genetically engineered models have advantages over xenografts for preclinical studies. Cancer Res 66: 3355–3358 discussion 3358–3359. · DOI · Paper page
- Belinsky SA, Klinge DM, Stidley CA, Issa JP, Herman JG, March TH et al. (2003). Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer. Cancer Res 63: 7089–7093.
- Belinsky SA, Stefanski SA, Anderson MW . (1993). The A/J mouse lung as a model for developing new chemointervention strategies. Cancer Res 53: 410–416.
- Castonguay A, Pepin P, Stoner GD . (1991). Lung tumorigenicity of NNK given orally to A/J mice: its application to chemopreventive efficacy studies. Exp Lung Res 17: 485–499. · doi:10.3109/01902149109064434
- Chiba I, Takahashi T, Nau MM, D’Amico D, Curiel DT, Mitsudomi T et al. (1990). Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene 5: 1603–1610.
- Greenblatt MS, Bennett WP, Hollstein M, Harris CC . (1994). Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855–4878.
- Hecht SS, Morse MA, Eklind KI, Chung FL . (1991). A/J mouse lung tumorigenesis by the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its inhibition by arylalkyl isothiocyanates. Exp Lung Res 17: 501–511. · doi:10.3109/01902149109064435
- Jackson EL, Olive KP, Tuveson DA, Bronson R, Crowley D, Brown M et al. (2005). The differential effects of mutant p53 alleles on advanced murine lung cancer. Cancer Res 65: 10280–10288. · DOI · Paper page
- Jaurand MC . (2005). Mesothelioma pathogenesis, facts and expectations. Pathol Biol (Paris) 53: 41–44. · DOI
- Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, Tuveson DA et al. (2001). Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410: 1111–1116. · DOI · Paper page
- Kerr KM, Lamb D, Wathen CG, Walker WS, Douglas NJ . (1992). Pathological assessment of mediastinal lymph nodes in lung cancer: implications for non-invasive mediastinal staging. Thorax 47: 337–341. · doi:10.1136/thx.47.5.337
- Kitamura H, Kameda Y, Ito T, Hayashi H . (1999). Atypical adenomatous hyperplasia of the lung. Implications for the pathogenesis of peripheral lung adenocarcinoma. Am J Clin Pathol 111: 610–622. · DOI · Paper page
- Liu G, McDonnell TJ, Montes de Oca Luna R, Kapoor M, Mims B, El-Naggar AK et al. (2000). High metastatic potential in mice inheriting a targeted p53 missense mutation. Proc Natl Acad Sci USA 97: 4174–4179. · DOI · Paper page
- Malkinson AM, You M . (1994). The intronic structure of cancer-related genes regulates susceptibility to cancer. Mol Carcinog 10: 61–65. · doi:10.1002/mc.2940100202
- Meuwissen R, Berns A . (2005). Mouse models for human lung cancer. Genes Dev 19: 643–664. · DOI · Paper page
- Mitsudomi T, Steinberg SM, Nau MM, Carbone D, D’Amico D, Bodner S et al. (1992). p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7: 171–180.
- Olak J, Colson Y . (2004). Gender differences in lung cancer: have we really come a long way, baby? J Thorac Cardiovasc Surg 128: 346–351. · doi:10.1016/j.jtcvs.2004.05.025
- Ordonez NG . (2003). The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma. Am J Surg Pathol 27: 1031–1051. · DOI · Paper page
- Payne S . (2001). ‘Smoke like a man, die like a man’?: a review of the relationship between gender, sex and lung cancer. Soc Sci Med 53: 1067–1080. · DOI
- Quint LE, Tummala S, Brisson LJ, Francis IR, Krupnick AS, Kazerooni EA et al. (1996). Distribution of distant metastases from newly diagnosed non-small cell lung cancer. Ann Thorac Surg 62: 246–250. · doi:10.1016/0003-4975(96)00220-2
- Rodenhuis S, Slebos RJ . (1992). Clinical significance of ras oncogene activation in human lung cancer. Cancer Res 52(9 Suppl): 2665s–2669s.
- Rodenhuis S, Slebos RJ, Boot AJ, Evers SG, Mooi WJ, Wagenaar SS et al. (1988). Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res 48: 5738–5741.
- Sadikot RT, Renwick DS, DaCosta P, Chalmers AG, Pearson SB . (1997). Breast metastasis from non-small cell lung cancer. South Med J 90: 1063–1064. · doi:10.1097/00007611-199710000-00021
- Salgia R, Skarin AT . (1998). Molecular abnormalities in lung cancer. J Clin Oncol 16: 1207–1217. · DOI · Paper page
- Sausville EA, Burger AM . (2006). Contributions of human tumor xenografts to anticancer drug development. Cancer Res 66: 3351–3354, discussion 3354. · DOI · Paper page
- Takahashi T, Nau MM, Chiba I, Birrer MJ, Rosenberg RK, Vinocour M et al. (1989). p53: a frequent target for genetic abnormalities in lung cancer. Science 246: 491–494. · DOI · Paper page
- Tamura A, Matsubara O, Yoshimura N, Kasuga T, Akagawa S, Aoki N . (1992). Cardiac metastasis of lung cancer. A study of metastatic pathways and clinical manifestations. Cancer 70: 437–442. · doi:10.1002/1097-0142(19920715)70:2<437::aid-cncr2820700211>3.0.co;2-l
- Toyooka S, Tsuda T, Gazdar AF . (2003). The Tp53 gene, tobacco exposure, and lung cancer. Hum Mutat 21: 229–239. · DOI · Paper page
- Vahakangas KH, Bennett WP, Castren K, Welsh JA, Khan MA, Blomeke B et al. (2001). p53 and K-ras mutations in lung cancers from former and never smoking women. Cancer Res 61: 4350–4356.
- Wang Y, Zhang Z, Lubet RA, You M . (2006a). A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice. Oncogene 25: 1277–1280. · DOI
- Wang Y, Zhang Z, Yao R, Jia D, Wang D, Lubet RA et al. (2006b). Prevention of lung cancer progression by bexarotene in mouse models. Oncogene 25: 1320–1329. · DOI
- You M, Wang Y, Stoner G, You L, Maronpot R, Reynolds SH et al. (1992). Parental bias of Ki-ras oncogenes detected in lung tumors from mouse hybrids. Proc Natl Acad Sci USA 89: 5804–5808. · DOI
- Zang EA, Wynder EL . (1996). Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst 88: 183–192. · DOI · Paper page
Cited by
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
Chen, L., Gibbons, D. L., Goswami, S., Cortez, M. A., Ahn, Y.-H., Byers, L. A., Zhang, X., Yi, X., Dwyer, D., Lin, W., et al. (2014) · Nature Communications · doi:10.1038/ncomms6241 · Cited by 966
Self-citationWNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma Metastasis
Nguyen, D. X., Chiang, A. C., Zhang, X. H.-F., Kim, J. Y., Kris, M. G., Ladanyi, M., Gerald, W. L., & Massagué, J. (2009) · Cell · doi:10.1016/j.cell.2009.04.030 · Cited by 613
Gibbons, D. L., Lin, W., Creighton, C. J., Rizvi, Z. H., Gregory, P. A., Goodall, G. J., Thilaganathan, N., Du, L., Zhang, Y., Pertsemlidis, A., et al. (2009) · Genes & Development · doi:10.1101/gad.1820209 · Cited by 512
Self-citationRole of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer
Liu, G., Pei, F., Yang, F., Li, L., Amin, A., Liu, S., Buchan, J., & Cho, W. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020367 · Cited by 425
Metadata
- Authors
- Zheng, S., El-Naggar, A. K., Kim, E. S., Kurie, J. M., & Lozano, G.
- Venue
- Oncogene
- Published
- 2007-05-07
- Volume
- 26
- Issue
- 48
- Pages
- 6896-6904
- ISSN
- 0950-9232
- 1476-5594
- Cited by
- 95
- References
- 4
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A genetic mouse model for metastatic lung cancer with gender differences in survival. https://app.cochat.ai/papers/10.1038/sj.onc.1210493
- The paper
- Zheng, S., El-Naggar, A. K., Kim, E. S., Kurie, J. M., & Lozano, G. (2007). A genetic mouse model for metastatic lung cancer with gender differences in survival. Oncogene. https://doi.org/10.1038/sj.onc.1210493
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.